Report cover image

Impact of Inflation on the Healthcare Sector - Analyzing Trends by Key Countries, Physicians and Healthcare Professionals (HCPs) Perspective, Patient Treatment and Treatment Costs

Publisher GlobalData
Published Feb 08, 2023
Length 71 Pages
SKU # GBDT17791191

Description

Impact of Inflation on the Healthcare Sector - Analyzing Trends by Key Countries, Physicians and Healthcare Professionals (HCPs) Perspective, Patient Treatment and Treatment Costs

Summary

In 2022, many developed countries worldwide faced record-breaking inflation levels not seen for several decades. Post-COVID-19 supply chain disruptions, strong consumer demand, and Russia's ongoing conflict with Ukraine are among the main factors contributing to increasing financial constraints on consumers and businesses, as well as a prolonged gloomy economic outlook.

In this “Inflation in the Healthcare - Physician Perspective” report, GlobalData examines the impact of inflation on healthcare systems, patients, and HCPs. The report provides an overview of the current and future outlook of the healthcare sector, government policies, innovative technologies, and initiatives that are expected to help combat inflation in the healthcare.

Key findings from this report include the following:
  • The healthcare industry is set to face new challenges such as inflation in a post-COVID-19 world
  • Even though inflation is decreasing, it will remain elevated in 2023, continuing to pressure the healthcare sector
  • Risings costs triggered patients to postpone or stop treatments in 2022
  • It will take more than two years for the number of patients stopping or postponing treatments due to rising healthcare costs to stabilize
  • “Out of pocket” costs became an important factor for patients when choosing a treatment in 2022
  • Surveyed HCPs expected drug prices to grow with inflation rate
  • Despite the pharma industry’s skepticism, US -HCPs believe that the Inflation Reduction Act could lead to lower drug prices
  • Drug pricing control and movement towards preventive care were highlighted as the top solutions to reduce inflation in the healthcare sector
Key Highlights

Despite decreasing inflation rates, the healthcare sector will face turbulent times in 2023

Rising costs forced patients to postpone or stop treatments in 2022 and it will take years for the backlogs to clear

Drug pricing control and movement towards preventive care may be reliable methods to reduce inflation in the healthcare sector

Scope

This report combines information obtained from secondary sources and primary research with healthcare professionals (HCPs) to assess the impact of inflation on healthcare systems, patients, and HCPs in the US, Japan, France, Italy, Germany, Spain, and the UK.

Study objectives
  • Assess the impact of inflation on the healthcare sector
  • Highlight the impact of inflation on patient treatment
  • Capture physicians’ opinions on drug price growth
  • Identify possible inflation reduction measures in the healthcare sector
  • Explore physicians’ views on inflation reduction acts, such as the IRA
Reasons to Buy
  • Get an overview on how inflation impacts healthcare sector
  • Discover implications on patient treatment
  • Explore physicians’ attitude toward the pharmaceutical drug pricing
  • See how physician perceive the inflation reduction policies, such as Inflation Reduction Act
  • Gain an understanding of inflation reduction measures in the healthcare sector

Table of Contents

71 Pages
1 Executive Summary
1.1 Executive Summary
2 Study Design
2.1 Objectives and Design
2.2 Respondent Mix
2.3 Respondent Profiles
3 Economic Outlook
3.1 Emerging Regulatory and Macroeconomic Trends
3.2 Inflation’s Impact on Pharmaceutical Value Chain
3.3 Industry’s Growth for the Next 12 Months
3.4 Economic Outlook - Major Markets Data
3.5 Health Spending
3.6 Retail Pharmaceutical Spending
4 Inflation in the US, 5EU, and Japan
4.1 Inflation - US
4.2 Inflation Reduction Policies - US
4.3 Inflation - France
4.4 Inflation - Germany
4.5 Inflation Reduction Policies in the EU - France and Germany
4.6 Inflation - Italy
4.7 Inflation - Spain
4.8 Inflation Reduction Policies in the EU - Italy and Spain
4.9 Gas and Electricity Prices for Household Consumers: France, Germany, Italy, and Spain
4.10 Inflation - UK
4.11 Inflation - Japan
4.12 Inflation Reduction Policies - UK and Japan
5 Inflation - Impact on Patient Treatment
5.1 Inflation - Impact on Patient Treatment: US
5.2 Pharma’s Annual Drug Price Increases - US
5.3 Inflation - Impact on Patient Treatment: France
5.4 Inflation - Impact on Patient Treatment: Germany
5.5 Inflation - Impact on Patient Treatment: Italy
5.6 Inflation - Impact on Patient Treatment: Spain
5.7 Inflation - Impact on Patient Treatment: UK
5.8 Inflation - Impact on Patient Treatment: Japan
6 Inflation - Drug Prices and Treatment Costs
6.1 Inflation - Treatment Costs: US
6.2 Inflation Reduction Act - a Closer Look
6.3 Inflation Reduction Act - HCP Perspective
6.4 Inflation - Treatment Costs: France
6.5 Inflation - Treatment Costs: Germany
6.6 Inflation - Treatment Costs: Italy
6.7 Inflation - Treatment Costs: Spain
6.8 Inflation - Treatment Costs: UK
6.9 NHS England Backlog Data - Consultant-led Elective Care
6.10 Inflation - Treatment Costs: Japan
7 Future Considerations
7.1 What Causes Inflation in Healthcare?
7.2 Inflation Reduction Measures
7.3 Inflation and Pharmaceutical Prices
7.4 Inflation Reduction Measures - Government Policies
8 Summary of Key Findings
8.1 Key Findings
9 Appendix 1
9.1 Authors
10 Appendix 2
10.1 Our Thematic Research Methodology
11 Contact Us
11.1 About GlobalData
11.2 Trusted Intelligence in Uncertain Times
11.3 Contact Us

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us